Testing effectiveness (Phase 2)Study completedNCT00174772What this trial is testingPulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)Who this might be right forLung Neoplasms Sanofi 72
Testing effectiveness (Phase 2)Looking for participantsNCT01720836What this trial is testingStudy of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer (NSCLC) Olivera Finn 30
Testing effectiveness (Phase 2)Looking for participantsNCT05473156What this trial is testingInvestigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected MalignanciesWho this might be right forLocally Advanced or Metastatic Solid TumorsNon Small Cell Lung Cancer (NSCLC)Head and Neck Squamous Cell Carcinoma (HNSCC)+1 more AP Biosciences Inc. 168
Post-approval studies (Phase 4)Ended earlyNCT00536107What this trial is testingStudy to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Who this might be right forCarcinoma, Non-Small-Cell Lung AstraZeneca 14
Large-scale testing (Phase 3)Active Not RecruitingNCT06670196What this trial is testingSKB264 in Combination With Osimertinib Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutations, Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 420
Not applicableStudy completedNCT00256789What this trial is testingOnce Weekly Radiation for Lung Cancer With ChemotherapyWho this might be right forCarcinoma, Non-Small-Cell Lung Clinical Oncology Research Associates 26
Large-scale testing (Phase 3)Looking for participantsNCT06928389What this trial is testingIvonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Akeso 536
Testing effectiveness (Phase 2)Looking for participantsNCT06706713What this trial is testingStudy of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung CancerEGFR Exon 20 Insertion Mutation BeBetter Med Inc 200
Early research (Phase 1)WithdrawnNCT05693090What this trial is testingTipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung CancerWho this might be right forNSCLC Kura Oncology, Inc.
Early research (Phase 1)Looking for participantsNCT07229313What this trial is testingKIVU-107 in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvance Solid Tumors Kivu Bioscience Inc. 76
Testing effectiveness (Phase 2)Looking for participantsNCT05592626What this trial is testingA Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more Marengo Therapeutics, Inc. 366
Not applicableEnded earlyNCT01647334What this trial is testingShrinking Target Adaptive Radiotherapy for Locally Advanced Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 29
Large-scale testing (Phase 3)Active Not RecruitingNCT05840016What this trial is testingAK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung CancerWho this might be right forAdvanced Squamous Non Small Cell Lung Cancer Akeso 532
Not applicableStudy completedNCT02596958What this trial is testingSafety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) ParticipantsWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 996
Testing effectiveness (Phase 2)Ended earlyNCT02387216What this trial is testingMM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLCWho this might be right forNon-Small Cell Lung CancerNSCLCAdenocarcinoma+1 more Elevation Oncology 153
Not applicableEnrolling By InvitationNCT06883136What this trial is testingEfficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly PatientsWho this might be right forNon-Small Cell Lung Cancer Qianfoshan Hospital 43
Testing effectiveness (Phase 2)Study completedNCT01029678What this trial is testingConcomitant Radio-chemotherapy in the ElderlyWho this might be right forNon Small Cell Lung Cancer University Hospital, Limoges 48
Testing effectiveness (Phase 2)Study completedNCT02875340What this trial is testingVAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell LungAdenocarcinoma ValiSeek Limited 8
Early research (Phase 1)Study completedNCT02535325What this trial is testingMethoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung CancerWho this might be right forLocally Advanced Lung Non-Squamous Non-Small Cell CarcinomaStage III Lung Adenocarcinoma AJCC v7Stage III Lung Large Cell Carcinoma AJCC v7+10 more National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT06792435What this trial is testingXNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.Who this might be right forPancreatic Adenocarcinoma MetastaticLung Cancer (NSCLC)Ovarian Cancer+4 more Astellas Pharma Global Development, Inc. 240